Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania

Kevin Frick, Matthew Lynch, Sheila K West, Beatriz Munoz, Harran A. Mkocha

Research output: Contribution to journalArticle

Abstract

Objective: Household willingness to pay for treatment provides important information for programme planning. We tested for relationships between socioeconomic status, risk of trachoma, perceptions of the effects of azithromycin, and the household willingness to pay for future mass treatment with azithromycin. Methods: We surveyed 394 households in 6 villages located in central United Republic of Tanzania regarding their willingness to pay for future azithromycin treatment. A random sample of households with children under 8 years of age was selected and interviewed following an initial treatment programme in each village. Data were gathered on risk factors for trachoma, socioeconomic status, and the perceived effect of the initial azithromycin treatment. Ordered probit regression analysis was used to test for statistically significant relationships. Findings: 38% of responding households stated that they would not be willing to pay anything for future azithromycin treatment, although they would be willing to participate in the treatment. A proxy for cash availability was positively associated with household willingness to pay for future antibiotic treatment. Cattle ownership (a risk factor) and being a household headed by a female not in a polygamous marriage (lower socioeconomic status) were associated with a lower willingness to pay for future treatment. A perceived benefit from the initial treatment was marginally associated with a willingness to pay a higher amount. Conclusions: As those at greatest risk of active trachoma indicated the lowest willingness to pay, imposing a cost recovery fee for azithromycin treatment would likely reduce coverage and could prevent control of the disease at the community level.

Original languageEnglish (US)
Pages (from-to)101-107
Number of pages7
JournalBulletin of the World Health Organization
Volume81
Issue number2
StatePublished - 2003

Fingerprint

Trachoma
Azithromycin
Tanzania
Social Class
Therapeutics
Fees and Charges
Ownership
Proxy
Marriage
Regression Analysis

Keywords

  • Azithromycin/therapeutic use/economics
  • Fees, Pharmaceutical
  • Forecasting
  • Risk factors
  • Socioeconomic factors
  • Trachoma/drug therapy
  • United Republic of Tanzania
  • Volition

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

@article{83a37519ca5f4d448d165f0c1fd5aa13,
title = "Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania",
abstract = "Objective: Household willingness to pay for treatment provides important information for programme planning. We tested for relationships between socioeconomic status, risk of trachoma, perceptions of the effects of azithromycin, and the household willingness to pay for future mass treatment with azithromycin. Methods: We surveyed 394 households in 6 villages located in central United Republic of Tanzania regarding their willingness to pay for future azithromycin treatment. A random sample of households with children under 8 years of age was selected and interviewed following an initial treatment programme in each village. Data were gathered on risk factors for trachoma, socioeconomic status, and the perceived effect of the initial azithromycin treatment. Ordered probit regression analysis was used to test for statistically significant relationships. Findings: 38{\%} of responding households stated that they would not be willing to pay anything for future azithromycin treatment, although they would be willing to participate in the treatment. A proxy for cash availability was positively associated with household willingness to pay for future antibiotic treatment. Cattle ownership (a risk factor) and being a household headed by a female not in a polygamous marriage (lower socioeconomic status) were associated with a lower willingness to pay for future treatment. A perceived benefit from the initial treatment was marginally associated with a willingness to pay a higher amount. Conclusions: As those at greatest risk of active trachoma indicated the lowest willingness to pay, imposing a cost recovery fee for azithromycin treatment would likely reduce coverage and could prevent control of the disease at the community level.",
keywords = "Azithromycin/therapeutic use/economics, Fees, Pharmaceutical, Forecasting, Risk factors, Socioeconomic factors, Trachoma/drug therapy, United Republic of Tanzania, Volition",
author = "Kevin Frick and Matthew Lynch and West, {Sheila K} and Beatriz Munoz and Mkocha, {Harran A.}",
year = "2003",
language = "English (US)",
volume = "81",
pages = "101--107",
journal = "Bulletin of the World Health Organization",
issn = "0042-9686",
publisher = "World Health Organization",
number = "2",

}

TY - JOUR

T1 - Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania

AU - Frick, Kevin

AU - Lynch, Matthew

AU - West, Sheila K

AU - Munoz, Beatriz

AU - Mkocha, Harran A.

PY - 2003

Y1 - 2003

N2 - Objective: Household willingness to pay for treatment provides important information for programme planning. We tested for relationships between socioeconomic status, risk of trachoma, perceptions of the effects of azithromycin, and the household willingness to pay for future mass treatment with azithromycin. Methods: We surveyed 394 households in 6 villages located in central United Republic of Tanzania regarding their willingness to pay for future azithromycin treatment. A random sample of households with children under 8 years of age was selected and interviewed following an initial treatment programme in each village. Data were gathered on risk factors for trachoma, socioeconomic status, and the perceived effect of the initial azithromycin treatment. Ordered probit regression analysis was used to test for statistically significant relationships. Findings: 38% of responding households stated that they would not be willing to pay anything for future azithromycin treatment, although they would be willing to participate in the treatment. A proxy for cash availability was positively associated with household willingness to pay for future antibiotic treatment. Cattle ownership (a risk factor) and being a household headed by a female not in a polygamous marriage (lower socioeconomic status) were associated with a lower willingness to pay for future treatment. A perceived benefit from the initial treatment was marginally associated with a willingness to pay a higher amount. Conclusions: As those at greatest risk of active trachoma indicated the lowest willingness to pay, imposing a cost recovery fee for azithromycin treatment would likely reduce coverage and could prevent control of the disease at the community level.

AB - Objective: Household willingness to pay for treatment provides important information for programme planning. We tested for relationships between socioeconomic status, risk of trachoma, perceptions of the effects of azithromycin, and the household willingness to pay for future mass treatment with azithromycin. Methods: We surveyed 394 households in 6 villages located in central United Republic of Tanzania regarding their willingness to pay for future azithromycin treatment. A random sample of households with children under 8 years of age was selected and interviewed following an initial treatment programme in each village. Data were gathered on risk factors for trachoma, socioeconomic status, and the perceived effect of the initial azithromycin treatment. Ordered probit regression analysis was used to test for statistically significant relationships. Findings: 38% of responding households stated that they would not be willing to pay anything for future azithromycin treatment, although they would be willing to participate in the treatment. A proxy for cash availability was positively associated with household willingness to pay for future antibiotic treatment. Cattle ownership (a risk factor) and being a household headed by a female not in a polygamous marriage (lower socioeconomic status) were associated with a lower willingness to pay for future treatment. A perceived benefit from the initial treatment was marginally associated with a willingness to pay a higher amount. Conclusions: As those at greatest risk of active trachoma indicated the lowest willingness to pay, imposing a cost recovery fee for azithromycin treatment would likely reduce coverage and could prevent control of the disease at the community level.

KW - Azithromycin/therapeutic use/economics

KW - Fees, Pharmaceutical

KW - Forecasting

KW - Risk factors

KW - Socioeconomic factors

KW - Trachoma/drug therapy

KW - United Republic of Tanzania

KW - Volition

UR - http://www.scopus.com/inward/record.url?scp=0037289022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037289022&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 101

EP - 107

JO - Bulletin of the World Health Organization

JF - Bulletin of the World Health Organization

SN - 0042-9686

IS - 2

ER -